These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19082480)

  • 21. Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.
    Câmpean V; Karpe B; Haas C; Atalla A; Peters H; Rupprecht H; Liebner S; Acker T; Plate K; Amann K
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1174-84. PubMed ID: 18272601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2.
    Reiss Y; Knedla A; Tal AO; Schmidt MHH; Jugold M; Kiessling F; Burger AM; Wolburg H; Deutsch U; Plate KH
    J Pathol; 2009 Mar; 217(4):571-80. PubMed ID: 19116989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
    Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
    Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.
    Wang GM; Kovalenko B; Huang Y; Moscatelli D
    Prostate; 2007 Apr; 67(5):485-99. PubMed ID: 17221843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
    Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time PCR study of Ang1, Ang2, Tie-2, VEGF, and KDR expression in human erectile tissue during aging.
    Figueiredo A; Cordeiro AL; Tomada N; Tomada I; Rodrigues A; Gouveia A; Neves D
    J Sex Med; 2011 May; 8(5):1341-51. PubMed ID: 21091880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
    Zhang ZL; Liu ZS; Sun Q
    World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling.
    Stone OA; Carter JG; Lin PC; Paleolog E; Machado MJ; Bates DO
    J Physiol; 2017 Mar; 595(5):1575-1591. PubMed ID: 27868196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis.
    Tuo QH; Zeng H; Stinnett A; Yu H; Aschner JL; Liao DF; Chen JX
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2547-57. PubMed ID: 18408125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
    Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
    J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
    Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
    Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
    Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system.
    Rizkalla B; Forbes JM; Cao Z; Boner G; Cooper ME
    J Hypertens; 2005 Jan; 23(1):153-64. PubMed ID: 15643138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis.
    Yamakawa M; Liu LX; Belanger AJ; Date T; Kuriyama T; Goldberg MA; Cheng SH; Gregory RJ; Jiang C
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F649-57. PubMed ID: 15198927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
    Chernoguz A; Crawford K; Donovan E; Vandersall A; Berglund C; Cripe TP; Frischer JS
    J Surg Res; 2012 Mar; 173(1):1-9. PubMed ID: 21658718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis.
    Matsunaga T; Warltier DC; Tessmer J; Weihrauch D; Simons M; Chilian WM
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H352-8. PubMed ID: 12649074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
    Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
    Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.